Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: E Louis J, M Resche-Rigon, D Laharie, J Satsangi, N Ding, J Preiss, G D’Haens, L Picon, P Bossuyt, L Vuitton, P Irving, Y Bouhnik, S Viennot, C Lamb, R Pollock, F Baert, M Nachury, F Mathurin, C Gilletta, J F Colombel, E Hertervig

Journal title: Journal of Crohn's and Colitis

Journal number: 16(1)

Journal publisher: Elsevier Science

Published year: 2022

Published pages: Page i001

DOI identifier: 10.1093/ecco-jcc/jjab232.000

ISSN: 1873-9946